Two months after postponing offer, Celladon nets $44.3mm in refiled Nasdaq IPO
- Gene Therapy, Cell Therapy
- Drug Delivery
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.